48 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
serves on the board of directors of Sorriso Pharmaceuticals, Inc. Dr. Sherman holds a B.A. in Biology from Lake Forest College and a M.D. from
8-K
nt45iqsmjky712n
3 Oct 23
Departure of Directors or Certain Officers
4:31pm
8-K
EX-99.2
4tdyebfi7z0evd y6
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
cd6x9hu2
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
EX-99.2
58ksno ttv3qr7k3at
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
mcfphdut6fxc1wdg21
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
idmhk2l4pjokwndv
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
06xb0zy id6r1880xve
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
4gyjiot
28 Feb 22
Results of Operations and Financial Condition
8:16am